{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T07:53:20Z","timestamp":1788076400729,"version":"build-2784847793"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AJOG Global Reports"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.xagr.2022.100064","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T13:57:21Z","timestamp":1654869441000},"page":"100064","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["An evaluation into the use of procalcitonin levels as a biomarker of bacterial sepsis to aid the management of intrapartum pyrexia and chorioamnionitis"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8126-9156","authenticated-orcid":false,"given":"Sarah","family":"Walker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irasha","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Soomro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Bamber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Carrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul H.","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel E.","family":"Liebling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xagr.2022.100064_bib0001","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/tog.12623","article-title":"Maternal sepsis update: current management and controversies","volume":"22","author":"Greer","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xagr.2022.100064_bib0002","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/aogs.13346","article-title":"Procalcitonin; a feasible biomarker for severe bacterial infections in obstetrics and gynecology?","volume":"97","author":"Tujula","year":"2018","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.xagr.2022.100064_bib0003","unstructured":"National Institute for Health and Care Excellence. Procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay). 2015. Available at: http:\/\/www.nice.org.uk\/guidance\/dg18. Accessed March 28, 2022."},{"key":"10.1016\/j.xagr.2022.100064_bib0004","doi-asserted-by":"crossref","first-page":"15","DOI":"10.7196\/sajog.1397","article-title":"Serum procalcitonin in pregnancy-associated sepsis: a case control study","volume":"25","author":"Agarwal","year":"2019","journal-title":"S Afr J Obstet Gynaecol"},{"key":"10.1016\/j.xagr.2022.100064_bib0005","doi-asserted-by":"crossref","first-page":"S514","DOI":"10.1016\/j.ajog.2017.11.401","article-title":"864: Usefulness of measuring procalcitonin (PTC) in pregnancy for the initial diagnosis of bacterial infection with systemic features","volume":"218","author":"Velasquez","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2022.100064_bib0006","unstructured":"Roche Diagnostics. Electrochemiluminescence immunoassay \u201cECLIA\u201d for the in vitro quantitative determination of PCT (procalcitonin) in human serum and plasma. 2022. Available at: https:\/\/diagnostics.roche.com\/global\/en\/products\/params\/elecsys-brahms-procalcitonin-pct.html. Accessed March 28, 2022."},{"key":"10.1016\/j.xagr.2022.100064_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002984","article-title":"Incidence of maternal peripartum infection: a systematic review and meta-analysis","volume":"16","author":"Woodd","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.xagr.2022.100064_bib0008","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.clp.2010.02.003","article-title":"Diagnosis and management of clinical chorioamnionitis","volume":"37","author":"Tita","year":"2010","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.xagr.2022.100064_bib0009","unstructured":"Royal College of Obstetricians and Gynaecologists. Sepsis in pregnancy, Bacterial (Green-top Guideline No. 64a). 2012. Available at: https:\/\/www.rcog.org.uk\/guidance\/browse-all-guidance\/green-top-guidelines\/sepsis-in-pregnancy-bacterial-green-top-guideline-no-64a\/. Accessed March 28, 2022."},{"key":"10.1016\/j.xagr.2022.100064_bib0010","unstructured":"National Institute for Health and Care Excellence. Intrapartum care for women with existing medical conditions or obstetric complications and their babies. 2019. Available at:https:\/\/www.nice.org.uk\/guidance\/ng121. Accessed March 28, 2022."},{"key":"10.1016\/j.xagr.2022.100064_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2017.02.022","article-title":"Incidence of fever in labor and risk of neonatal sepsis","volume":"216","author":"Towers","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2022.100064_bib0012","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1159\/000453611","article-title":"Risk factors for intrapartum fever in term gestations and associated maternal and neonatal sequelae","volume":"82","author":"Burgess","year":"2017","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.xagr.2022.100064_bib0013","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/1471-0528.15799","article-title":"Specific class of intrapartum antibiotics relates to maturation of the infant gut microbiota: a prospective cohort study","volume":"127","author":"Coker","year":"2020","journal-title":"BJOG"},{"key":"10.1016\/j.xagr.2022.100064_bib0014","doi-asserted-by":"crossref","first-page":"10635","DOI":"10.1038\/s41598-019-46964-5","article-title":"Impact of intrapartum and postnatal antibiotics on the gut microbiome and emergence of antimicrobial resistance in infants","volume":"9","author":"Tapiainen","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.xagr.2022.100064_bib0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s40560-017-0246-8","article-title":"Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy","volume":"5","author":"Vijayan","year":"2017","journal-title":"J Intensive Care"},{"key":"10.1016\/j.xagr.2022.100064_bib0016","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1515\/cclm-2018-1181","article-title":"Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use","volume":"57","author":"Schuetz","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.xagr.2022.100064_bib0017","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10024-003-7070-y","article-title":"Amniotic infection syndrome: nosology and reproducibility of placental reaction patterns","volume":"6","author":"Redline","year":"2003","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.xagr.2022.100064_bib0018","doi-asserted-by":"crossref","first-page":"698","DOI":"10.5858\/arpa.2015-0225-CC","article-title":"Sampling and definitions of placental lesions: Amsterdam placental workshop group consensus statement","volume":"140","author":"Khong","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.xagr.2022.100064_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2014.03.010","article-title":"The Sepsis in Obstetrics Score: a model to identify risk of morbidity from sepsis in pregnancy","volume":"211","author":"Albright","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2022.100064_bib0020","first-page":"232","article-title":"Development and implementation of an early-onset sepsis calculator to guide antibiotic management in late preterm and term Neonates","volume":"42","author":"Kuzniewicz","year":"2016","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"10.1016\/j.xagr.2022.100064_bib0021","unstructured":"Kaiser Permanente Division of Research. Neonatal early-onset sepsis calculator. 2022. Available at: https:\/\/neonatalsepsiscalculator.kaiserpermanente.org. Accessed March 28, 2022."},{"issue":"Suppl1","key":"10.1016\/j.xagr.2022.100064_bib0022","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.21037\/jtd.2019.11.63","article-title":"Role of procalcitonin use in the management of sepsis","volume":"12","author":"Gregoriano","year":"2020","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.xagr.2022.100064_bib0023","doi-asserted-by":"crossref","first-page":"ofw249","DOI":"10.1093\/ofid\/ofw249","article-title":"Using procalcitonin to guide antibiotic therapy","volume":"4","author":"Rhee","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.xagr.2022.100064_bib0024","doi-asserted-by":"crossref","first-page":"10651","DOI":"10.1016\/j.ijantimicag.2020.106051","article-title":"Procalcitonin levels in COVID-19 patients","volume":"56","author":"Hu","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.xagr.2022.100064_bib0025","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.7861\/clinmed.2020-0614","article-title":"Use of procalcitonin for antibiotic stewardship in patients with COVID-19: a quality improvement project in a district general hospital","volume":"21","author":"Peters","year":"2021","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.xagr.2022.100064_bib0026","article-title":"Lactate and procalcitonin levels in peripartum women with intraamniotic infection","volume":"3","author":"Do","year":"2021","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.xagr.2022.100064_bib0027","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cca.2020.12.007","article-title":"A pregnancy-specific reference interval for procalcitonin","volume":"513","author":"Dockree","year":"2021","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.xagr.2022.100064_bib0028","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1177\/00045632211005807","article-title":"Reference values for C-reactive protein and procalcitonin at term pregnancy and in the early postnatal period","volume":"58","author":"Joyce","year":"2021","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.xagr.2022.100064_bib0029","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3345\/kjp.2017.60.1.10","article-title":"The influencing factors on procalcitonin values in newborns with noninfectious conditions during the first week of life","volume":"60","author":"Lee","year":"2017","journal-title":"Korean J Pediatr"},{"key":"10.1016\/j.xagr.2022.100064_bib0030","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/jama.2012.8262","article-title":"Does this adult patient with suspected bacteremia require blood cultures?","volume":"308","author":"Coburn","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.xagr.2022.100064_bib0031","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s15010-007-7065-0","article-title":"Serum procalcitonin for discrimination of blood contamination from bloodstream infection due to coagulase-negative staphylococci","volume":"35","author":"Schuetz","year":"2007","journal-title":"Infection"},{"key":"10.1016\/j.xagr.2022.100064_bib0032","doi-asserted-by":"crossref","first-page":"e2264","DOI":"10.1097\/MD.0000000000002264","article-title":"Can we reduce negative blood cultures with clinical scores and blood markers? Results from an observational cohort study","volume":"94","author":"Laukemann","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.xagr.2022.100064_bib0033","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1017\/S0965539511000015","article-title":"Histological chorioamnionitis: current concepts of diagnosis, classification and clinical significance","volume":"22","author":"Jessop","year":"2011","journal-title":"Fetal Matern Med Rev"},{"key":"10.1016\/j.xagr.2022.100064_bib0034","first-page":"1000","article-title":"Clinical chorioamnionitis and histologic placental inflammation","volume":"94","author":"Smulian","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xagr.2022.100064_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.531543","article-title":"Maternal-fetal inflammation in the placenta and the developmental origins of health and disease","volume":"11","author":"Goldstein","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.xagr.2022.100064_bib0036","doi-asserted-by":"crossref","first-page":"e31819","DOI":"10.1371\/journal.pone.0031819","article-title":"Acute histologic chorioamnionitis at term: nearly always noninfectious","volume":"7","author":"Roberts","year":"2012","journal-title":"PLoS One"}],"container-title":["AJOG Global Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666577822000156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666577822000156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:19:44Z","timestamp":1763000384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666577822000156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S2666577822000156"],"URL":"https:\/\/doi.org\/10.1016\/j.xagr.2022.100064","relation":{},"ISSN":["2666-5778"],"issn-type":[{"value":"2666-5778","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An evaluation into the use of procalcitonin levels as a biomarker of bacterial sepsis to aid the management of intrapartum pyrexia and chorioamnionitis","name":"articletitle","label":"Article Title"},{"value":"AJOG Global Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xagr.2022.100064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100064"}}